Results

Total Results: 1,401 records

Showing results for "adverse".

201. Urinary-Incontinence-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
     April 01, 2012 - effects, and discontinuation due to adverse effects. … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse … Risk of adverse effects was greater with trospium than with placebo. … Adverse effects were common with all drugs and varied between the drugs. … Treatment discontinuation due to adverse effects of drugs is common.

202. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - Serious transfusion-related adverse events are uncommon. … For example, in the United States, adverse events due to errors in transfusion are Comparative Effectiveness … A review of these various trials may help maximize benefit, optimize drug usage, and minimize adverse … For other adverse events, reporting is incomplete, representing less than one-third of patients. … More evidence is needed to delineate the effects on survival, tumor progression, and risk of adverse

203. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - When lesinurad was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, the experts warned that lesinurad uptake could be limited by concern about adverse events, … adverse events, than patients given placebo. … Adverse events/nonfatal serious adverse events rates were 78.1%/8.6% and 82.4%/12.9% in patients who … ; treatment-emergent adverse event rates were not reported.

204. ADHD-Update-protocol-160818 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
     August 18, 2016 - NEBA is used to provide clinical support but does not replace the clinical evaluation.14 Adverse … Adverse Effects of Treatment: Adverse effects associated with pharmacologic treatment can include changes … Adverse effects of nonpharmacologic treatment depend on the specific intervention. … These adverse effects are not likely to expand beyond those expected for pharmacologic therapy. … § Adverse effects of treatment include changes in appetite, growth suppression, weight decrease,

205. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - Similar to RA trials, many questions remain about the risks of these agents across a spectrum of adverse … KQ 3: For patients with PsA, do drug therapies differ in harms, tolerability, patient adherence, or adverse … events, and specific adverse events if data were available (e.g., injection-site reactions, infections … Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo. … Information generally was insufficient for the comparative harms, tolerability, adverse events, and

206. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - adverse events according to drug class? … Harms and Adverse Events ...................................................................... … Harms and Adverse Events a. … adverse events, according to drug class? … events, and serious adverse events.

207. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - of these medications is supported by several systematic reviews.8-12 Due to the potential serious adverse … The proposed advantages over anticholinergics include potentially lower rates of adverse effects and … We will synthesize available data regarding efficacy, comparative effectiveness and adverse effects … Also, adverse events may occur at any point after the treatment is initiated. IV. Methods A. … Update on AUA guideline on the review of efficacy and adverse effects.

208. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - But it is well recognized that regimens vary in their potential for long-term adverse effects, so this … Mitigation of long-term adverse effects by changes in regimen, including reduced-intensity approaches … Mitigation of long-term adverse effects by changes in regimen, including reduced- intensity approaches … But, it is well recognized that regimens vary in their potential for long-term adverse effects. … Role of novel therapies for HSCT in altering short-term adverse effects and the long-term effects of

209. Weight-Loss-Surgery Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
     June 01, 2013 - had no adverse events data. … Thus, strength of evidence for long-term adverse events is rated insufficient. … Data reported on adverse events also have several limitations. … event category; thus, the rate estimate for most adverse events is imprecise. … As such, the rates of adverse events may be biased and lower than actual.

210. Medical Care Journal Supplement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events. … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse … A Simulation-Based Evaluation of Methods to Estimate the Impact of an Adverse Event on Hospital Length

211. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
     February 01, 2008 - , bone density, and cosmetic adverse effects? … Based on the comments received and input from the Technical Expert Panel, the adverse events listed … effects • Cosmetic adverse events • Incidence of adverse events • Incidence of individual adverse … events • Incidence of adverse events resulting in therapy withdrawal • Incidence of adverse events … not resulting in therapy withdrawal • Skin rash • Neurological adverse events • Suicidal ideation

212. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
     July 01, 2014 - Treatment may lead to intermediate outcomes, such as changes in level of depression symptoms, or adverse … reports, adverse events associated with discontinuation of treatment, and serious adverse events … • Withdrawals from study and discontinuation of treatment due to adverse events • All-cause mortality … events, discontinuation due to adverse events, and weight gain. … Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.

213. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
     October 12, 2015 - adverse outcomes, and in some cases preferences for process as well as outcome. … Short-term adverse effects of treatments !! OHSS 6! … Short-term adverse effects of treatments !! OHSS !! Surgical complications !! … Adverse!effects!of!treatments!(e.g.,!for!PCOS!patients,! gastrointestinal![GI]!symptoms!for! … adverse!effects!of!treatments! !! OHSS! !! Surgical!complications! !! Adverse!effects!of!

214. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
     September 18, 2024 - quality of life, as well as our secondary outcomes such as pain intensity, medication usage, and adverse … Several reviewers pointed out that adverse events (AE) are not a major concern with behavioral treatments … noted that we discussed overall dropouts in the AE section, but such dropouts may not actually be adverse

215. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - CKD, the kidneys are damaged and/ or cannot filter blood normally.1 CKD increases the risk for many adverse … • Few trials reported adverse events. … • Although limitations in reporting impeded the quantitative synthesis of withdrawal and adverse … positive tests (for progression); medication adverse effects; increased medical visits; increased … CKD Treatment Harms Knowledge Gaps Withdrawals and adverse events were reported in few RCTs.

216. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - of the various adverse events were not always comparable." … Limitations of evaluation of adverse events have been added to Discussion section. … Discussion Adverse effects: “There is a moderate level of evidence to show that adverse events associated … These long-term adverse events need to be explored in future studies. … types of adverse events were different between groups, as would be expected.

217. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
     February 17, 2016 - single classes on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse … postoperative) on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse … KQ 5 also §   Symptomatic DVT §   Proximal DVT o   Adherence (compliance) with treatment •   Adverse … events due to mechanical devices (as reported by authors) o   Adverse events due to IVC filter (as … reported by authors) o   Other clinically significant adverse events reported by studies

218. Pharmacologic Management of Acute Pain by EMS in the Prehospital Setting Protocol Amendment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
     January 28, 2019 - of individuals have insufficient prehospital pain relief.3 Reasons for this have included fear of adverse … of their abuse and the resulting epidemic in the United States.9,10 When combined with concerns of adverse … event (as in any subject that experienced an adverse event during the study period) • KQ2c: o … Predictors of pain relief and adverse events in patients receiving opioids in a prehospital setting. … event (as in any subject that experienced an adverse event during the study period).

219. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - Comparison of adverse events and complications across the various interventions is difficult. … Thirty-seven of these studies reported on adverse events. … Adverse events (including 30-day mortality, Table B) Adverse events were reported in 37 studies, including … Other adverse events reported included hemorrhage and hematomas, and renal artery occlusion. … Adverse events N/A • The evidence does not support meaningful conclusions about relative adverse events

220. Cer-250-Cannabis-2025-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-table-e5.xlsx
     January 01, 2025 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse